SCHEMBL16640673

SCHEMBL16640673

CC(O)(c1ccccc1)[C@@H]1C[C@@H](O)CN1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.39
CYP2D6 P10635 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
MAN2A1 Q16706 1/20 0.37
MAN1B1 Q9UKM7 1/20 0.37
GBA1 P04062 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
HRH1 P35367 1/20 0.35
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
CHRM3 P20309 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12896205 0.84 CYP2D6 (0.51) MAPK1CYP2D6KDM4ENPC1CYP1A2
SCHEMBL6801407 0.74 KDM4E (0.31) MAPK1CYP2D6KDM4ENPC1CYP1A2
SCHEMBL6855483 0.74 KDM4E (0.31) MAPK1CYP2D6KDM4ENPC1CYP1A2
SCHEMBL20832962 0.74 CYP2C19 (0.56) MAPK1CYP2D6KDM4ENPC1CYP1A2
SCHEMBL20832965 0.74 CYP2C19 (0.56) MAPK1CYP2D6KDM4ENPC1CYP1A2
SCHEMBL25337905 0.74 CYP2C19 (0.56) MAPK1CYP2D6KDM4ENPC1CYP1A2
SCHEMBL22259825 0.74 CYP2C19 (0.56) MAPK1CYP2D6KDM4ENPC1CYP1A2
SCHEMBL13894842 0.73 GBA1 (0.34) GBA1
SCHEMBL10326842 0.71 CYP2D6 (0.61) MAPK1CYP2D6KDM4ENPC1CYP1A2
SCHEMBL10326922 0.71 CYP2D6 (0.61) MAPK1CYP2D6KDM4ENPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701601-B2 Optically active axially chiral alpha-allenic alcohol, synthesis method and use thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2017-07-11 US disclosed
US-20150105567-A1 OPTICALLY ACTIVE AXIALLY CHIRAL ALPHA-ALLENIC ALCOHOL, SYNTHESIS METHOD AND USE THEREOF SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105567-A1 OPTICALLY ACTIVE AXIALLY CHIRAL ALPHA-ALLENIC ALCOHOL, SYNTHESIS METHOD AND USE THEREOF ALDH18A1, ADH1C, ADH1A MAPK1 2277/4885CYP2D6 1087/4885KDM4E 3179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.